Manifold MarketsNo KYCVerified resolution dataFairly calibratedData quality warningSource data degraded
Data as of Oct 26, 2026, 4:02 AM UTC · policy pm-quality-4
Current community forecastNo 85.7%
Forecasters
18
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 2 hours ago
StaleAug 3, 23, 6:56 PM UTCJan 2, 28, 7:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will Jumping Heel Click advance past the Emoji Subcommittee's first review stage?
Manifold MarketsIsrael x Hamas Ceasefire Phase II by which date?
PolymarketIsrael x Hamas Ceasefire Phase II by which date?
FutuurSkin cancer vaccine BLA submitted by which date?
PolymarketIs Cheryl Scott from ABC CHICAGO pregnant????!?!??? 🤰
Manifold MarketsAnthropic lab leak by which date?
PolymarketRules
Recently the small molecule drug AOH1996 has recieved some attention on social media for its potential to treat a variety of cancers with basically no side effects in animal models.
- Here is a good overview: https://www.science.org/content/blog-post/new-mode-cancer-treatment
- The question here is whether this drug will succeed in Phase II trials.
- Unlike the ongoing Phase I trials, which are designed to show safety, Phase II trails must show efficacy.
- Success can unambiguously be defined as either FDA approval (under an accelerated approval process, which this drug may get) or advancing to Phase III trails.
- (Note that in Phase III trials a drug is evaluated for comparative efficacy against other treatment options).
